T

Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075

Watchlist Manager
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
Watchlist
Price: 56.69 CNY 1.05%
Market Cap: 4.5B CNY

Intrinsic Value

The intrinsic value of one Tibet Duo Rui Pharmaceutical Co Ltd stock under the Base Case scenario is 7.73 CNY. Compared to the current market price of 56.69 CNY, Tibet Duo Rui Pharmaceutical Co Ltd is Overvalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
7.73 CNY
Overvaluation 86%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
Tibet Duo Rui Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Tibet Duo Rui Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Tibet Duo Rui Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tibet Duo Rui Pharmaceutical Co Ltd.

Explain Valuation
Compare Tibet Duo Rui Pharmaceutical Co Ltd to

Fundamental Analysis

Tibet Duo Rui Pharmaceutical Co Ltd
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Tibet Duo Rui Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tibet Duo Rui Pharmaceutical Co Ltd

Current Assets 565.2m
Cash & Short-Term Investments 332.8m
Receivables 147.1m
Other Current Assets 85.3m
Non-Current Assets 885.4m
Long-Term Investments 107.8m
PP&E 676.3m
Intangibles 96.9m
Other Non-Current Assets 4.5m
Current Liabilities 455.8m
Accounts Payable 46m
Accrued Liabilities 4.2m
Short-Term Debt 309.4m
Other Current Liabilities 96.2m
Non-Current Liabilities 360.6m
Long-Term Debt 174m
Other Non-Current Liabilities 186.6m
Efficiency

Free Cash Flow Analysis
Tibet Duo Rui Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tibet Duo Rui Pharmaceutical Co Ltd

Revenue
177.1m CNY
Cost of Revenue
-153.8m CNY
Gross Profit
23.3m CNY
Operating Expenses
-178.8m CNY
Operating Income
-155.5m CNY
Other Expenses
30.1m CNY
Net Income
-125.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tibet Duo Rui Pharmaceutical Co Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Strong 3Y Average Gross Margin
Healthy Gross Margin
Declining Gross Margin
Declining Net Margin
22/100
Profitability
Score

Tibet Duo Rui Pharmaceutical Co Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tibet Duo Rui Pharmaceutical Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
53/100
Solvency
Score

Tibet Duo Rui Pharmaceutical Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tibet Duo Rui Pharmaceutical Co Ltd

There are no price targets for Tibet Duo Rui Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tibet Duo Rui Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Tibet Duo Rui Pharmaceutical Co Ltd stock?

The intrinsic value of one Tibet Duo Rui Pharmaceutical Co Ltd stock under the Base Case scenario is 7.73 CNY.

Is Tibet Duo Rui Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 56.69 CNY, Tibet Duo Rui Pharmaceutical Co Ltd is Overvalued by 86%.

Back to Top